IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Keep in touch with IntegrChain through our news and frequent events.
View all news & events
More than a decade ago, IntegriChain pioneered channel data aggregation, data stewardship and governance as well as advanced analytics. Enhanced by data science, our solutions make specialty pharmacy, retail pharmacy, distributor and patient services data actionable. With the help of private equity support, IntegriChain has expanded our business to include managed services and an application platform across key related disciplines including government pricing, rebate management and gross-to-net. We recently joined forces with Cumberland Life Sciences, a leading provider of contracts and pricing related managed services, advisory services, and system integration services.
IntegriChain now has the largest managed services platform in the industry, supporting more than 150 manufacturer customers every day. We also have grown team of world-class commercialization and market access experts to more than 400. Today, our global IntegriChain team is uniquely positioned to address critical therapy access challenges throughout the drug commercialization life cycle, ensuring that patients have access to their life-saving and life-changing medicines as needed and minimizing the chances that they forego therapy.
“IntegriChain maintains a laser-like focus on helping patients get and stay on therapies they need. We do this with our relentless, customer-centric focus and innovation that enables life sciences manufacturers to quickly identify and eliminate all types of access-related obstacles throughout the brand life cycle, from pre-launch through growth.”
Kevin Leininger Co-Founder and CEO
From improving launch readiness to enabling regulatory compliance and access to government programs as well as optimizing distribution and patient access strategies and programs, IntegriChain plays a vital role in enabling our customers to make better and faster payer, channel and patient support decisions. In fact, more than 250 life science manufacturers— ranging from pre-commercial manufacturers to Big Pharma and including 20 of the Top-20 companies rely on IntegriChain’s world-class data, managed and professional services. Together, we have participated in 71% of product launches over the past 2 years including 35 first launches. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm.
We are passionate about our customers’ mission – improving the lives of patients – and view it as our own.
Access Insights 2021 is taking place November 16-18. Stay tuned for registration info. Watch videos from our Virtual Event
We’re always looking for the best and brightest to join our tech team. See available careers today!
View Opportunities
We are a collective force of tech innovators and problem solvers with a laser focus on helping patients start therapy faster and stay on therapy longer. Learn more about careers at IntegriChain.